Journal of Family Planning and Reproductive Health Care

Prosecution of rape and sexual assault
pp. 115-117(3)
Author: Connelly C.

Rape: The victim's perspective
pp. 117-120(4)
Author: Tinsley H.

The problem of rape and supporting victims
pp. 120-122(3)
Author: Harne L.

One in four: Providing emotional support to female victims of domestic violence
pp. 122-123(2)
Author: Buckingham A.

Sexual abuse and learning disability
pp. 123-124(2)
Author: Cooper E.

Drug-facilitated rape
pp. 125-125(1)
Author: Cybulska B.

Progress for The Journal of Family Planning and Reproductive Health Care
pp. 126-126(1)
Author: Reader F.

Assisting and advising complainants of sexual assault in the family planning setting
pp. 127-131(5)
Author: Rogers D.J.

Question Sheet
pp. 131-131(1)

Uterine balloon therapy for menorrhagia: A feasibility study of its use in the community setting
pp. 133-134(2)
Authors: McAllister K.F.; Bigrigg A.

Atrophic vulvovaginitis in women aged 50 years and above, both current and non-users of hormone replacement therapy, attending a genitourinary medicine clinic
pp. 135-136(2)
Authors: Tobin J.; Harindra V.

The evolution of the Marie Stopes electrocautery no-scalpel vasectomy procedure
pp. 137-138(2)
Authors: Black T.; Francome C.

Answer Sheet
pp. 139-139(1)

A study to assess the prevalence of chronic testicular pain in post-vasectomy men compared to non-vasectomised men
pp. 142-144(3)
Authors: Morris C.; Mishra K.; Kirkman R.J.E.

Countywide survey of the current practice of chlamydia detection in primary care
pp. 145-148(4)
Authors: Shefras J.; Edmondson S.; McNulty C.

Clinical management of chlamydia in general practice: A survey of reported practice
pp. 149-152(4)
Authors: Griffiths C.; Cuddigan A.

Laboratory testing for Chlamydia trachomatis urogenital infections
pp. 153-154(2)
Author: Chan E.L.

Caesarean section scar ectopic pregnancy following postcoital contraception
pp. 155-156(2)
Authors: Fabunmi L.; Perks N.

Intrauterine device insertions: Setting our standards
pp. 157-158(2)
Authors: Kasliwal A.P.; Webb A.M.C.

Revisiting 'Fraser ruling competence' for under 16s in the UK
pp. 158-158(1)
Author: Vanhegan G.

Measuring risk: How, when and why?
pp. 159-161(3)
Authors: Simpson J.A.; Mollison J.; Hannaford P.C.

Bulletin Board
pp. 162-163(2)

Book Reviews
pp. 163-163(1)

Effects of oral contraceptives on risk of cervical cancer in women with human papilloma virus infection: the IARC multicentric case-control study. Moreno V, Bosch FX, Munoz N, et al. Lancet 2002; 399(9312): 1085-1092
pp. 164-164(1)
Author: Weaver K.

Role of parity and HPV in cervical cancer: the IARC muticentric case-control study. Munoz N, Franceschi S, Bosetti C, et al. Lancet 2002; 399(9312): 1093-1101
pp. 164-164(1)
Author: Wyllie A.

Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive device in lactating women. Bjarnadottir RI, Gottfredsdottir H, Sigurdardottir K, et al. Br J Obstet Gynaecol 2001; 108: 1174-1180
pp. 164-166(3)
Author: Brechin S.

Insertion of an intrauterine contraceptive device after induced or spontaneous abortion: a review of the evidence. Stanwood NL, Grimes DA, Schulz KF. Br J Obstet Gynaecol 2001; 108: 1168-1173
pp. 166-166(1)
Author: Brechin S.

Daily low dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double blind randomized control trial of 2 mg and 5 mg per day for 120 days. Brown A, Cheng L, Suiqing L, et al. J Clin Endocrinol Metab 2002; 87: 63-70
pp. 166-166(1)
Author: Cameron S.

Meetings and Courses
pp. 168-168(1)